Albany, NY -- (SBWIRE) -- 01/03/2018 -- Red biotechnology is the application of biotechnology in biopharmaceuticals and pharmaceuticals production. It provides patients with innovative and modern modes of diagnostics and treatments. This biotechnological application involves research and study on cells and tissues, genetic testing, stem cells, gene therapy, orphan drugs, proteomics and pharmacogenetics. The red biotechnology mainly focuses on neurosciences and protein research.

Read Report Overview: https://www.transparencymarketresearch.com/red-biotechnology-market.html

The global market for red biotechnology is categorized by applications and product types as follows:

Applications

Drug discovery
Drug production
Gentic testing
Pharmacogenomics
Gene therapy
Product type

Gene recombinant drugs
Human vaccines
Blood products
Diagnostics reagents
Others

Currently, North America dominates the global red biotechnology market and is followed by Europe due to increased introduction of new products in the developed markets and number of patents and intellectual property rights granted in the biomedical sector. Emerging economies of Asia-Pacific, Latin America, Middle East and Africa are also expected to emerge as rapidly growing red biotechnology market in the near future due to increasing healthcare expenditure and technological advances.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2063

Some of the major factors driving the global market for red biotechnology include breakthrough outcome of new medical therapies, increase in use of biocatalysis process in the synthesis and production of active pharmaceutical ingredients, advancements in biopharmaceuticals, increasing consumer awareness and government initiatives. However, high capital investment and technical limitations may pose a challenge to the growth of red biotechnology market.

Some of the market players in this industry include Amgen, Inc., Beijing Tiantan Biological Products Co., Ltd., Biogen Idec, Inc., Cephalon, Inc., Chiron Corporation, CSL Limited, Genentech, Inc., Genzyme Corporation, Gilead Sciences, Inc., MedImmune LLC, Serono SA and Shenyang Sunshine Pharmaceutical Co., Ltd.